Connect with us

Health

COVID deaths too high, Therapeutics Options too low; TCIG is not following Mother England

Published

on

By Deandrea Hamilton

Editor

 

#TurksandCaicos, January 20, 2022 – Five medical treatments for Covid-19 patients are in use in the United Kingdom according to National Health Service, (NHS) yet Turks and Caicos has employed only one Covid-19 therapeutic and with the surge in new deaths due to the virus, it is a wonder if more can be done in this country to save lives.

Dexamethasone was approved by the NHS in June 2020, less than a month later, Turks and Caicos Hospitals began use of the therapeutic said to offer ground-breaking coronavirus treatment.

“Dexamethasone, an anti-inflammatory drug, has been immediately approved to treat all UK hospitalised COVID-19 patients requiring oxygen, including those on ventilators, from today.

The drug has been proven to reduce the risk of death significantly in COVID-19 patients on ventilation by as much as 35% and patients on oxygen by 20%, reducing the total 28-day mortality rate by 17%,” informed a media statement from the NHS on June 16, 2020.

Ever so quietly, and despite repeated media questions to the Ministry of Health about therapeutics, Dexamethasone was added to the Covid-19 response arsenal without a word.

The TCI Hospitals informed of its use late 2021, due to Magnetic Media questions on the issue.

However, that is where the list of therapeutics ends.  But not so for the UK, from whom Turks and Caicos is taking medical cues.

Four other therapies are employed in the United Kingdom in an effort to save lives; they are: Tocilizumab and sarilumab (for REHAB); Tocilizumab (for RECOVERY); Inhaled budesonide (for PRINCIPLE care) and Ronapreve (for RECOVERY).

No surprise the effort is varied and fervent as the UK sadly reports one of the highest death tolls to COVID in the world at 153,000 people lost to the virus.

By January 2021, the UK, which was also the first country to approve emergency use of the Covid-19 vaccines, added a new drug: Tocilizumab and sarilumab.

Tocilizumab and sarilumab is administered to the sickest Covid-19 patients, said the NHS.

“This is a significant finding which could have immediate implications for the sickest patients with COVID-19,” said Professor Anthony Gordon, Chair in Anaesthesia and Critical Care at Imperial College London and a Consultant in Intensive Care Medicine at Imperial College Healthcare NHS Trust.

“We found that among critically ill adult patients – those receiving breathing support in intensive care – treatment with these drugs can improve their chances of survival and recovery,” explained Professor Gordon. “At a time when hospitalisations and deaths from COVID-19 are soaring in the UK, it’s crucial we continue to identify effective treatments which can help to turn the tide against this disease.”

A month later, a recovery version of Tocilizumab came on stream.

The NHS, which ran studies on all of the drugs before introducing them for medical care to its residents reported that:  “Treatment with tocilizumab significantly reduced deaths: 596 (29%) of the patients in the tocilizumab group died within 28 days compared with 694 (33%) patients in the usual care group (rate ratio 0·86; [95% confidence interval [CI] 0·77 to 0·96]; p=0·007), an absolute difference of 4%. This means that for every 25 patients treated with tocilizumab, one additional life would be saved.”

By April 2021, the UK was offering a therapeutic which was administered to people presenting with COVID but not yet hospitalised for the virus.

Inhaled budesonide, was given before Covid-19 turned severe.

“This asthma drug shortens recovery time said the National Health Service.  The statement published on April 12, 2021 said, “Inhaled budesonide, a common corticosteroid, is the first widely available, inexpensive drug found to shorten recovery times in COVID-19 patients aged over 50 who are treated at home and in other community settings, reports the PRINCIPLE trial in 1,779 participants. The drug is now available to treat COVID-19 on a case-by-case basis in UK primary care.”

The final approved “effective treatment” listed on the UK Government’s website is Ronapreve, sanctioned as effective in September 2021.

It was geared to health care workers without coronavirus antibodies and those 12 to 49, who are considered immunocompromised.

Health and Social Care Secretary Sajid Javid said: “We have secured a brand new treatment for our most vulnerable patients in hospitals across the UK and I am thrilled it will be saving lives from as early as next week.

The UK is leading the world in identifying and rolling out life-saving medicines, particularly for COVID-19, and we will continue our vital work to find the best treatments available to save lives and protect the NHS.

Ronapreve is the first neutralising antibody medicine specifically designed to treat COVID-19 to be authorised by the Medicines and Healthcare products Regulatory Agency (MHRA) for use in the UK.”

Given the Turks and Caicos, as a UK Overseas Territory has been extraordinarily supported from the onset of the pandemic by the United Kingdom, it is unclear why only one of five options, approved by Mother England has been activated locally.

While all messages from the NHS reveal a zeal to have as many possible options for the people of the UK in the fight against COVID-19.  Turks and Caicos seems stuck and lacking the motivation  it needs to offer more life-saving treatments to the people – vaccinated or unvaccinated – of the territory.

Perhaps the knowledge of the cold corpses of six beloved people from January 2022 deaths due to COVID, including a special needs young woman, may get the government spending public money on the other drugs and treatments, which give Covid-19 patients an extra fighting chance at life.

 

 

Continue Reading

Health

Grand Turk Residents Fear Norovirus-Linked Cruise as Health Ministry Approves Docking

Published

on

Turks and Caicos, May 22, 2026 – Residents in Grand Turk raised concerns last week after a cruise ship previously linked to a major norovirus outbreak was cleared to dock in the Turks and Caicos Islands days after passengers were reportedly denied disembarkation in The Bahamas over health fears.

According to the US Centers for Disease Control and Prevention, the outbreak sickened 115 people — including 102 passengers and 13 crew members — during a voyage which ran from April 28 to May 11. The illnesses involved symptoms commonly associated with norovirus, including vomiting and diarrhea.

The outbreak became public on May 7 and quickly triggered concern across the region.

Authorities in Nassau reportedly refused to allow passengers off the vessel because of public health concerns connected to the outbreak.

That decision later fueled anxiety among some Turks and Caicos residents when the ship proceeded to Grand Turk on May 15.

Residents’ concerns were not without cause.

Norovirus is a highly contagious viral illness often associated with cruise ships, hotels, schools and other environments where large groups of people share close quarters. The virus primarily causes sudden vomiting, diarrhea, stomach cramps and nausea, and spreads rapidly through contaminated food, water, surfaces and person-to-person contact.

According to the US Centers for Disease Control and Prevention, most healthy people recover within one to three days, but norovirus can become serious — and occasionally fatal — for elderly individuals, young children and people with weakened immune systems because of severe dehydration. While the overall fatality rate is considered very low, the CDC estimates norovirus contributes to hundreds of deaths annually in the United States, mainly among vulnerable populations.

The Turks and Caicos Ministry of Health and Human Services had said in a press statement on May 15, it believed the risks had been effectively neutralized before the vessel arrived in Grand Turk.

In a statement issued Thursday, the Ministry said the ship had already returned to Florida, where passengers disembarked and “comprehensive sanitization and deep-cleaning procedures were completed” before operations resumed.

The Ministry also stressed that its Public Health Team maintained “close and continuous communication” with the ship’s medical personnel, Carnival Cruise Line officials and stakeholders at the Grand Turk Cruise Centre before approving the docking.

Routine inspections and standard port health procedures were also carried out, according to officials.

The Ministry further reassured the public that there were “currently no public health concerns” associated with the vessel’s arrival.

Still, the situation once again highlighted the delicate balancing act Caribbean nations face between protecting public health and sustaining tourism economies heavily dependent on cruise arrivals.

Officials are now encouraging vendors, taxi operators, tour companies and businesses to continue practicing strong sanitation and hygiene measures as an added precaution.

Residents were also reminded that frequent handwashing remains one of the most effective ways to prevent the spread of norovirus and other infectious illnesses.

Angle by Deandrea Hamilton. Built with ChatGPT (AI). Magnetic Media — CAPTURING LIFE.

Continue Reading

Health

29 Million Strong, the World Salutes Nurses as International Nurses Day is Observed

Published

on

On Tuesday May 12, the world pauses to honor one of humanity’s most trusted, exhausted, resilient and indispensable professions — nursing.

International Nurses Day is observed annually on the birthday of Florence Nightingale, widely regarded as the founder of modern nursing, and comes at a time when global healthcare systems continue to rely heavily on nurses carrying extraordinary emotional, physical and professional burdens.

According to the World Health Organization, there are an estimated 29 million nurses worldwide, making nursing the largest professional group within the global healthcare workforce. Yet despite their numbers, many countries continue to face severe nursing shortages, burnout crises and migration challenges as healthcare demands rise faster than staffing levels.

Still, nurses remain the heartbeat of healthcare.

They are present at life’s first breath and often its final moments. They work through hurricanes, pandemics, emergencies and violence. They calm fear, interpret pain, comfort families and frequently become the bridge between doctors, patients and hope itself.

In small island nations like those across the Caribbean, nurses often carry even greater responsibility — serving communities where resources may be stretched, specialists limited and healthcare systems under constant pressure.

This year’s observance again shines a spotlight not only on the compassion nurses bring to their profession, but also on the growing global call for better pay, safer working environments, improved mental health support and stronger investment in healthcare staffing.

For many people, the most memorable face in healthcare is not always the surgeon or specialist — it is the nurse who stayed a little longer, explained a little more gently or cared a little more deeply during a difficult moment.

Tomorrow’s observance is therefore more than ceremonial.

It is a reminder that behind every functioning hospital, clinic, emergency room, health center, operating theatre and recovery ward stands a nurse — often overworked, sometimes underappreciated, but consistently essential.

To nurses across The Bahamas, Turks and Caicos, the Caribbean and the wider world: thank you for showing up, even on the hardest days.

Developed by Deandrea Hamilton • with ChatGPT (AI) • edited by Magnetic Media.

Continue Reading

Government

$94.1Mfor Health; Knowles Pushes to Keep Care at Home

Published

on

Turks and Caicos, April 25, 2026 – A major shift in how healthcare is delivered in the Turks and Caicos Islands is at the center of the Government’s latest budget, with a focus on reducing reliance on overseas treatment and strengthening services at home.

Presenting his contribution to the national debate, Kyle Knowles outlined a strategy aimed at building a more sustainable healthcare system—one that allows more residents to access quality care within the country.

The health sector has been allocated $94.1 million, making it one of the largest areas of public spending in the $550.8 million Budget passed on April 23.

Central to the Minister’s approach is a restructuring of the Treatment Abroad Programme (TAP), which has grown significantly in recent years as more patients are sent overseas for specialized care.

The Government now aims to reverse that trend.

“We are reforming healthcare to ensure long-term sustainability,” Knowles indicated, pointing to efforts to strengthen local services and reduce the need for travel.

The strategy includes improving healthcare infrastructure, expanding services available within the islands and increasing efficiency through the digitization of medical records.

Digitization is expected to support better coordination of care, reduce delays and allow for more accurate tracking of patient needs—part of a broader effort to modernize public services.

The Minister emphasized that the goal is not only cost control, but improved access.

“No family should have to leave home to get quality care,” he said, underscoring the Government’s intention to refocus healthcare delivery on local capacity.

The shift comes as rising healthcare costs continue to place pressure on public finances, with overseas treatment representing one of the most expensive components of the system.

By investing more heavily in domestic services, the Government is seeking to reduce that burden while improving outcomes for residents.

While the direction is clear, details on timelines and the pace of expansion for local services were not fully outlined in the presentation.

Still, the emphasis on sustainability, access and modernization signals a strategic pivot in how healthcare is expected to evolve in the Turks and Caicos Islands.

Angle by Deandrea Hamilton. Built with ChatGPT (AI). Magnetic Media — CAPTURING LIFE.

Continue Reading

FIND US ON FACEBOOK

TRENDING